WhiteSwell
Ballybrit
About WhiteSwell
WhiteSwell is a science-driven company dedicated to improving the treatment of acute decompensated heart failure (ADHF), which is a leading cause of hospitalization and emergency room visits. The WhiteSwell team investigated the therapeutic potential of the lymphatic system in order to address this significant clinical need. Its solution is unique in that it allows fluid removal from both the interstitial and intravascular compartments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $30.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2018)
- Website: whiteswell.com
- Phone: +353 91 394 110
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/whiteswell-53900 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.